A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Latest action: Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310) · May 14, 2026

View full text on Congress.gov ↗ Policy area: Health